Generate Biomedicines pushes machine learning to create new protein drugs
Generate Biomedicines is using machine learning in the U.S. to design new protein drugs. Its pipeline includes candidates for severe asthma and CAR-T cell therapy.
Protein therapeutics 1 article
Recombinant therapeutic proteins define protein therapeutics as a protein-based treatment modality with a specific biotechnology role. At a practical level, engineered protein medicines and cytokine therapeutics determine how the entity is implemented or measured, with enzyme replacement proteins and fusion protein therapeutics marking important downstream uses. The taxonomy keeps the concept level distinct, with recombinant therapeutic proteins and engineered protein medicines serving as characteristics rather than alternative names for protein therapeutics.